血栓症治療薬の世界市場2019-2023

◆英語タイトル:Global Thrombosis Drugs Market 2019-2023
◆商品コード:IRTNTR30379
◆発行会社(リサーチ会社):Technavio
◆発行日:2018年11月28日
◆ページ数:109
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥267,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥321,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、血栓症治療薬の世界市場について調査・分析し、市場概要、市場環境、血栓症治療薬市場規模、疾患別(肺塞栓症、深部静脈血栓症(DVT))分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・血栓症治療薬の世界市場概要
・血栓症治療薬の世界市場環境
・血栓症治療薬の世界市場動向
・血栓症治療薬の世界市場規模
・血栓症治療薬の世界市場:業界構造分析
・血栓症治療薬の世界市場:疾患別(肺塞栓症、深部静脈血栓症(DVT))
・血栓症治療薬の世界市場:地域別市場規模・分析
・血栓症治療薬の北米市場規模・予測
・血栓症治療薬のヨーロッパ・中東・アフリカ市場規模・予測
・血栓症治療薬のアジア太平洋市場規模・予測
・血栓症治療薬の主要国分析
・血栓症治療薬の世界市場:意思決定フレームワーク
・血栓症治療薬の世界市場:成長要因、課題
・血栓症治療薬の世界市場:競争環境
・血栓症治療薬の世界市場:関連企業情報(ベンダー分析)

主な分析対象企業は、Boehringer Ingelheim、Bristol-Myers Squibb、DAIICHI SANKYO、Johnson & Johnson、Sanofiなどです。
【レポートの概要】

About this market
Sedentary lifestyle is resulting in an increase in the number of thrombosis cases. The increase in sedentary lifestyle is leading to the rise in the prevalence of obesity across the world, thus increasing the risk of thrombosis. Technavio’s analysts have predicted that the thrombosis drugs market will register a CAGR of more than 9% by 2023.
Market Overview
Growing awareness of cardiac care
The increasing awareness of cardiac care is leading to the early diagnosis of various cardiac diseases. Various awareness camps have been organized by the governments and non-government organizations across the world to increase the awareness of heart health among the population.
Strong side-effects of anticoagulants
Anticoagulants or blood thinners are medications that are developed to dissolve blood clots in the body. Blood thinners have high efficacy. However, the side effects associated with the use of these drugs to treat thrombosis are high.
For the detailed list of factors that will drive and challenge the growth of the thrombosis drugs market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be concentrated and with the presence of several companies including Johnson & Johnson, and Sanofi the competitive environment is quite intense. Factors such as the increase in sedentary lifestyle and the increasing awareness of cardiac care, will provide considerable growth opportunities to thrombosis drugs manufactures. Boehringer Ingelheim, Bristol-Myers Squibb, DAIICHI SANKYO, Johnson & Johnson, and Sanofi are some of the major companies covered in this report.

‘With the presence of a considerable number of companies, this market appears to be concentrated and with all companies constantly focusing improving their market positions, the competitive environment among the players is quite intense. The market is witnessing the entry of various generic drug manufacturing companies that are coming up with generic versions of the drugs.’

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: PIPELINE
PART 07: MARKET SEGMENTATION BY INDICATION
• Market segmentation by indication
• Comparison by indication
• Pulmonary embolism – Market size and forecast 2018-2023
• DVT – Market size and forecast 2018-2023
• Market opportunity by indication
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• Americas – Market size and forecast 2018-2023
• EMEA – Market size and forecast 2018-2023
• APAC – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Boehringer Ingelheim
• Bristol-Myers Squibb
• DAIICHI SANKYO
• Johnson & Johnson
• Sanofi
PART 14: APPENDIX
• Research methodology
• List of abbreviations
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Years in consideration
Exhibit 02: Global hematology drugs market
Exhibit 03: Segments of global hematology drugs market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Global thrombosis drugs market pipeline: Overview
Exhibit 19: Indication – Market share 2018-2023 (%)
Exhibit 20: Comparison by indication
Exhibit 21: Pulmonary embolism – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Pulmonary embolism – Year-over-year growth 2019-2023 (%)
Exhibit 23: DVT – Market size and forecast 2018-2023 ($ millions)
Exhibit 24: DVT – Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by indication
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: Americas – Market size and forecast 2018-2023 ($ millions)
Exhibit 30: Americas – Year-over-year growth 2019-2023 (%)
Exhibit 31: EMEA – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: EMEA – Year-over-year growth 2019-2023 (%)
Exhibit 33: APAC – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: APAC – Year-over-year growth 2019-2023 (%)
Exhibit 35: Key leading countries
Exhibit 36: Market opportunity
Exhibit 37: Decision framework
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Boehringer Ingelheim – Vendor overview
Exhibit 45: Boehringer Ingelheim – Business segments
Exhibit 46: Boehringer Ingelheim – Organizational developments
Exhibit 47: Boehringer Ingelheim – Geographic focus
Exhibit 48: Boehringer Ingelheim – Segment focus
Exhibit 49: Boehringer Ingelheim – Key offerings
Exhibit 50: Boehringer Ingelheim – Key customers
Exhibit 51: Bristol-Myers Squibb – Vendor overview
Exhibit 52: Bristol-Myers Squibb – Business segments
Exhibit 53: Bristol-Myers Squibb – Organizational developments
Exhibit 54: Bristol-Myers Squibb – Geographic focus
Exhibit 55: Bristol-Myers Squibb – Key offerings
Exhibit 56: Bristol-Myers Squibb – Key customers
Exhibit 57: DAIICHI SANKYO – Vendor overview
Exhibit 58: DAIICHI SANKYO – Business segments
Exhibit 59: DAIICHI SANKYO – Organizational developments
Exhibit 60: DAIICHI SANKYO – Geographic focus
Exhibit 61: DAIICHI SANKYO – Key offerings
Exhibit 62: DAIICHI SANKYO – Key customers
Exhibit 63: Johnson & Johnson – Vendor overview
Exhibit 64: Johnson & Johnson – Business segments
Exhibit 65: Johnson & Johnson – Organizational developments
Exhibit 66: Johnson & Johnson – Geographic focus
Exhibit 67: Johnson & Johnson – Segment focus
Exhibit 68: Johnson & Johnson – Key offerings
Exhibit 69: Johnson & Johnson – Key customers
Exhibit 70: Sanofi – Vendor overview
Exhibit 71: Sanofi – Business segments
Exhibit 72: Sanofi – Organizational developments
Exhibit 73: Sanofi – Geographic focus
Exhibit 74: Sanofi – Segment focus
Exhibit 75: Sanofi – Key offerings
Exhibit 76: Sanofi – Key customers
Exhibit 77: Validation techniques employed for market sizing
Exhibit 78: List of abbreviations



【掲載企業】

Boehringer Ingelheim、Bristol-Myers Squibb、DAIICHI SANKYO、Johnson & Johnson、Sanofi

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[血栓症治療薬の世界市場2019-2023]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆